Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer to identify targetable BRCA alterations and AR resistance mechanisms.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Hanna Tukachinsky, Russell Madison, Jon Chung, Lucas Dennis, Bernard Fendler, Samantha Morley, Lei Zhong, Ryon Graf, Jeffrey S. Ross, Brian M Alexander, Wassim Abida, Simon Chowdhury, Charles J. Ryan, Karim Fizazi, Anthony A. Golsorkhi, Simon Paul Watkins, Andrew Simmons, Andrea Loehr, Jeffrey Venstrom, Geoffrey R. Oxnard
Institutions: Foundation Medicine (United States), SUNY Upstate Medical University, Memorial Sloan Kettering Cancer Center, St Thomas' Hospital, Sarah Cannon Research Institute, King's College Hospital, University of Minnesota, Université Paris-Sud, Institut Gustave Roussy, Clovis Oncology (United States), Clovis Oncology (United Kingdom)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3134226231